SEARCH

SEARCH BY CITATION

References

  • Alte D, Luedemann J, Rose HJ, & John U. (2004) Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the study of health in Pomerania (SHIP). Alcohol Clin Exp Res 28, 931940.
  • Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, & Wittert GA. (2011) Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 96, 30073019.
  • Arnlov J, Pencina MJ, Amin S, Nam BH, Benjamin EJ, Murabito JM et al. (2006) Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med 145, 176184.
  • Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al. (2010) Adverse events associated with testosterone administration. N Engl J Med 363, 109122.
  • Blouin K, Boivin A, & Tchernof A. (2008) Androgens and body fat distribution. J Steroid Biochem Mol Biol 108, 272280.
  • Bochud M & Rousson V. (2011) Usefulness of mendelian randomization in observational epidemiology. Int J Environ Res Public Health 7, 711728.
  • Bochud M, Marquant F, Marques-Vidal PM, Vollenweider P, Beckmann JS, Mooser V, Paccaud F, & Rousson V. (2009) Association between C-reactive protein and adiposity in women. J Clin Endocrinol Metab 94, 39693977.
  • Cameron AC & Triveldi PK. (2008) Microeconometrics: Methods and Applications. Cambridge University Press, New York.
  • Cook NL & Romashkan S. (2011) Why do we need a trial on the effects of testosterone therapy in older men? Clin Pharmacol Ther 89, 2931.
  • Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM, & Liu S. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 361, 11521163.
  • Dörr M, Wallaschofski H, & Friedrich N. (2009) Association of low total testosterone levels and prevalent carotid plaques: result of the study of health in Pomerania. Eur J Epidemiol 24, 389391.
  • Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ et al. (2010) Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95, 25602575.
  • Friedrich N, Volzke H, Rosskopf D, Steveling A, Krebs A, Nauck M, & Wallaschofski H. (2008) Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl 29, 610617.
  • Hardin JW & Hilbe JM. (2007) Generalized linear Models and Extensions, 2nd edn. Stata Press, College Station.
  • Haring R, Alte D, Volzke H, Sauer S, Wallaschofski H, John U, & Schmidt CO. (2009a) Extended recruitment efforts minimize attrition but not necessarily bias. J Clin Epidemiol 62, 252260.
  • Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C, & Wallaschofski H. (2009b) Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 58, 20272031.
  • Haring R, Ittermann T, Volzke H, Krebs A, Zygmunt M, Felix SB, Grabe HJ, Nauck M, & Wallaschofski H. (2010a) Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male 13, 247257.
  • Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M, & Wallaschofski H. (2010b) Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 31, 14941501.
  • Haring R, Wallaschofski H, Nauck M, Felix SB, Schmidt CO, Dorr M, Sauer S, Wilmking G, & Volzke H. (2010c) Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes 118, 685691.
  • Haring R, Baumeister S, Volzke H, Dorr M, Kocher T, Nauck M, & Wallaschofski H. (2011a) Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress. J Androl. [Epub ahead of print]. PMID: 22207707.
  • Haring R, Baumeister SE, Völzke H, Dorr M, Felix SB, Kroemer HK, Nauck M, & Wallaschofski H. (2011b) Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil 18, 8696.
  • Haring R, Nauck M, Volzke H, Endlich K, Lendeckel U, Friedrich N, Dorr M, Rettig R, Kroemer HK, & Wallaschofski H. (2011c) Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol 33, 209217.
  • Haring R, Spielhagen C, & Nauck M. (2011d) Challenges in the measurement of serum testosterone concentrations as a biomarker of men's health. Laboratoriumsmedizin 35, 2933.
  • Jones TH. (2010) Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab: TEM 21, 496503.
  • Kaufman JM & Vermeulen A. (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26, 833876.
  • Kivimaki M, Smith GD, Timpson NJ, Lawlor DA, Batty GD, Kahonen M et al. (2008) Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the cardiovascular risk in Young Finns study. Eur Heart J 29, 25522560.
  • Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, & McKinlay JB. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab 91, 843850.
  • Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, & Salonen JT. (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90, 712719.
  • Lawlor DA, Harbord RM, Sterne JA, Timpson N, & Davey Smith G. (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27, 11331163.
  • Maggio M & Basaria S. (2009) Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 21, 261264.
  • Ohlsson C, Wallaschofski H, Lunetta KL, Stolk L, Perry JR, Koster A et al. (2011) Genetic determinants of serum testosterone concentrations in men. PLoS Genet 7, e1002313.
  • Perry JR, Weedon MN, Langenberg C, Jackson AU, Lyssenko V, Sparso T et al. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 19, 535544.
  • Pierce BL, Ahsan H, & Vanderweele TJ. (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40, 740752.
  • Rassen JA, Schneeweiss S, Glynn RJ, Mittleman MA, & Brookhart MA. (2009) Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol 169, 273284.
  • Rothman KJ & Greenland S. (2005) Causation and causal inference in epidemiology. Am J Public Health 95(Suppl 1), S144S150.
  • Ruige JB, Mahmoud AM, De Bacquer D, & Kaufman JM. (2010) Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (British Cardiac Society) 97, 870875.
  • Sartorius G, Spasevska S, Idan A, Turner L, Forbes E, Zamojska A et al. (2012) Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). doi: 10.1111/j.1365-2265.2012.04432.x [Epub ahead of print]. PMID: 22563890.
  • Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM et al. (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland coronary prevention study. Circulation 108, 414419.
  • Smith GD, Timpson N, & Ebrahim S. (2008) Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Ann Med 40, 524541.
  • Steyerberg EW. (2008) Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Springer, Heidelberg.
  • Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, Michael K et al. (2011) A genome-wide association study of metabolic traits in human urine. Nat Genet 43, 565569.
  • Torkler S, Wallaschofski H, Baumeister SE, Volzke H, Dorr M, Felix S, Rettig R, Nauck M, & Haring R. (2011) Inverse association between total testosterone concentrations, incident hypertension and blood pressure. Aging Male 14, 176182.
  • Vikan T, Schirmer H, Njolstad I, & Svartberg J. (2010) Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. Eur J Endocrinol 162, 747754.
  • Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N et al. (2011) Cohort profile: the study of health in pomerania. Int J Epidemiol 40, 294307.